Document Type : Original Article

Authors

1 Organ Procurement Unit (OPU), Lung Transplantation Research Center (LTRC), National Research Institute of Tuberculosis and Lung Diseases (NRITLD), Shahid Beheshti University of Medical Sciences (SBMU), Tehran, Iran

2 Shiraz Transplantation Center, Namazi Hospital, Shiraz University of Medical Sciences, Shiraz, Iran (SBMU), Tehran, Iran

10.21859/pmj04012

Abstract

Nowadays, there has been a considerable advance of personalized medicine on a
scientific basis and clinical demands in cardiovascular diseases. This study investigated
a history of coronary artery bypass graft surgery a strong determinant of inferiority of
organ in cadaveric liver donation. In this study, fate of 14 potential deceased liver
donors with a history of coronary artery bypass graft surgery has been investigated.
This report shows that careful gross and microscopic investigation of the liver is the
key to extract suitable life savior livers from donors with advanced age.

Keywords

1.Lee MS, Flammer AJ, Lerman LO, Lerman A. Personalized
medicine in cardiovascular diseases. Korean Circ J.
2012;42(9):583-91. doi: 10.4070/kcj.2012.42.9.583 pmid:
23091501
2. Vodkin I, Kuo A. Extended Criteria Donors in Liver
Transplantation. Clin Liver Dis. 2017;21(2):289-301. doi:
10.1016/j.cld.2016.12.004 pmid: 28364814
3. Attia M, Silva MA, Mirza DF. The marginal liver donor--an
update. Transpl Int. 2008;21(8):713-24. doi: 10.1111/j.1432-
2277.2008.00696.x pmid: 18492121
4. Busuttil RW, Tanaka K. The utility of marginal donors in liver
transplantation. Liver Transpl. 2003;9(7):651-63. doi:
10.1053/jlts.2003.50105 pmid: 12827549
5. Spitzer AL, Lao OB, Dick AA, Bakthavatsalam R, Halldorson
JB, Yeh MM, et al. The biopsied donor liver: incorporating
macrosteatosis into high-risk donor assessment. Liver Transpl.
2010;16(7):874-84. doi: 10.1002/lt.22085 pmid: 20583086
6. Seket B, Abdelaal A, Gelas T, Pittau G, Dumortier J, Vanhems
P, et al. Back-table reconstruction of the donor replaced right
hepatic artery prior to liver transplantation: what is the real
impact on arterial complications? Hepatogastroenterology.
2009;56(91-92):756-62. pmid: 19621697
7. Mojtabaee M, Shamsaeefar A, Gholami S, Mohsenzadeh M,
Sadegh Beigee F. Impact of a Full-Time Donor Management
Protocol on Donors' Liver Biopsy Findings: Progress to Date.
Exp Clin Transplant. 2017;15(Suppl 1):269-72. doi:
10.6002/ect.mesot2016.P135 pmid: 28260484